Riitta Veijola Selected Research

HLA Antigens (Human Leukocyte Antigens)

1/2022	Autoantibodies to N-terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes.
1/2022	Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes.
11/2020	Maternal Nitrate and Nitrite Intakes during Pregnancy and Risk of Islet Autoimmunity and Type 1 Diabetes: The DIPP Cohort Study.
1/2019	Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
1/2019	No Association Between Ljungan Virus Seropositivity and the Beta-cell Damaging Process in the Finnish Type 1 Diabetes Prediction and Prevention Study Cohort.
1/2018	Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic children.
1/2018	Infant Feeding in Relation to the Risk of Advanced Islet Autoimmunity and Type 1 Diabetes in Children With Increased Genetic Susceptibility: A Cohort Study.
1/2018	Ketoacidosis at diagnosis of type 1 diabetes: Effect of prospective studies with newborn genetic screening and follow up of risk children.
6/2013	Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
10/2011	Validation of the Finnish ISAAC questionnaire on asthma against anti-asthmatic medication reimbursement database in 5-year-old children.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riitta Veijola Research Topics

Disease

142	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 05/2002
11	Infections 01/2023 - 08/2006
7	Genetic Predisposition to Disease (Genetic Predisposition) 03/2023 - 10/2006
7	Asthma (Bronchial Asthma) 10/2022 - 10/2011
6	Insulinoma 01/2023 - 06/2013
6	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 10/2006
6	Enterovirus Infections 10/2022 - 06/2012
6	Disease Susceptibility (Diathesis) 09/2022 - 10/2009
5	Milk Hypersensitivity (Milk Allergy) 10/2022 - 08/2014
5	Disease Progression 01/2022 - 06/2008
5	Celiac Disease (Celiac Sprue) 01/2020 - 04/2010
4	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2023 - 12/2008
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 11/2011
4	Hypersensitivity (Allergy) 01/2015 - 05/2011
3	Glucose Intolerance 09/2022 - 08/2015
2	Inflammation (Inflammations) 08/2023 - 01/2021
2	Allergic Rhinitis 10/2022 - 01/2013
2	Adenoviridae Infections (Adenovirus Infections) 01/2020 - 08/2006
1	Frailty 12/2021
1	Malaria 01/2021
1	Parasitemia 01/2021

Drug/Important Bio-Agent (IBA)

80	AutoantibodiesIBA 05/2024 - 05/2002
36	1,3-di(4-imidazolinophenoxyl)propaneIBA 12/2023 - 02/2008
35	Insulin (Novolin)FDA Link 05/2024 - 12/2005
21	AntibodiesIBA 05/2024 - 08/2006
14	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 09/2006
13	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2024 - 10/2006
13	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 12/2008
12	AntigensIBA 01/2022 - 12/2005
10	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2015
8	Fatty Acids (Saturated Fatty Acids)IBA 03/2023 - 12/2011
7	Immunoglobulin G (IgG)IBA 01/2019 - 06/2012
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2009
5	HLA-DQ Antigens (HLA-DQ)IBA 01/2023 - 01/2011
5	Immunoglobulin E (IgE)IBA 11/2021 - 01/2010
4	AutoantigensIBA 12/2022 - 05/2002
4	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2011
4	LipidsIBA 01/2022 - 12/2008
4	HLA-DR Antigens (HLA-DR)IBA 11/2020 - 11/2011
4	Glutens (Glutelin)IBA 01/2020 - 05/2015
4	Vitamin D FDA LinkGeneric 01/2019 - 01/2016
3	Metformin (Glucophage)FDA LinkGeneric 12/2023 - 01/2022
3	Peptides (Polypeptides)IBA 01/2023 - 05/2015
3	Amino Acids FDA Link 01/2023 - 12/2008
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2022 - 12/2011
3	25-hydroxyvitamin DIBA 01/2019 - 11/2014
3	HLA-DQB1 antigen (HLA DQB1)IBA 01/2019 - 03/2004
3	Immunoglobulin M (IgM)IBA 04/2014 - 06/2012
3	AllergensIBA 05/2011 - 01/2010
2	SugarsIBA 01/2023 - 12/2019
2	VaccinesIBA 01/2023 - 01/2018
2	CytokinesIBA 01/2023 - 03/2007
2	Zinc Transporter 8IBA 12/2022 - 11/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2022 - 02/2012
2	alpha-Linolenic Acid (Linolenic Acid)IBA 10/2022 - 12/2011
2	AntioxidantsIBA 01/2021 - 08/2008
2	C-PeptideIBA 01/2021 - 02/2012
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2020 - 05/2015
2	hydroxide ionIBA 01/2019 - 11/2014
2	GliadinIBA 05/2015 - 05/2015
2	Palmitic Acid (Hexadecanoic Acid)IBA 03/2014 - 12/2011
1	AdipokinesIBA 08/2023
1	LeptinIBA 08/2023
1	AdiponectinIBA 08/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2023
1	HexosesIBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	LigandsIBA 01/2023
1	interleukin-21 (interleukin 21)IBA 01/2023
1	adenovirus receptorIBA 01/2023
1	Poliovirus VaccinesIBA 01/2023
1	Threonine (L-Threonine)FDA Link 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Quinic Acid (Quinate)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Trans Fatty AcidsIBA 10/2022
1	Linoleic Acid (Linoleate)IBA 10/2022
1	Pattern Recognition ReceptorsIBA 10/2022
1	IFIH1 Interferon-Induced HelicaseIBA 10/2022
1	Liraglutide FDA Link 10/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2022
1	IncretinsIBA 10/2022
1	antineoplaston A10 (A 10)IBA 09/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	GAD65 (96-585)IBA 01/2022
1	IronIBA 03/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	NitritesIBA 11/2020
1	NitratesIBA 11/2020
1	CC ChemokinesIBA 11/2020
1	IntegrinsIBA 11/2020
1	CeramidesIBA 01/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2020
1	ProinsulinIBA 01/2020
1	Methionine (L-Methionine)FDA Link 12/2019

Therapy/Procedure

7	Therapeutics 01/2023 - 02/2012
3	Secondary Prevention 01/2023 - 01/2022